A 6-Week Open Label Cross-Over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE) - No Study Results Posted

A 6-Week Open Label Cross-Over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE) (PALAT)

This study has been completed.

Study NCT00209261 Information provided by Ferring Pharmaceuticals

First Received: September 13, 2005 Last Updated: February 19, 2009 History of Changes

No Study Results Posted for this Study

About Study Results Reporting

Study Status:	This study has been completed.
Estimated Study Completion Date:	September 2005
Primary Completion Date:	August 2005 (Final data collection date for primary outcome measure)